US 9585921
Compositions and methods
granted A61KA61K35/37A61K35/74
Quick answer
US patent 9585921 (Compositions and methods) held by Seres Therapeutics, Inc. expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Seres Therapeutics, Inc.
- Grant date
- Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K35/37, A61K35/74, A61K35/741, A61K35/742